ArticleQuantitative imaging in medicine and surgery2020
Combination of generative adversarial network and convolutional neural network for automatic subcentimeter pulmonary adenocarcinoma classification.
Article in Quantitative imaging in medicine and surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- AI-Driven Advances in Low-Dose Imaging and Enhancement-A Review.Diagnostics (Basel, Switzerland) · 2025Review
- Convolutional neural network of age-related trends digital radiographs of medial clavicle in a Thai population: a preliminary study.Anatomy & cell biology · 2023Article
- Deep learning for predicting epidermal growth factor receptor mutations of non-small cell lung cancer on PET/CT images.Quantitative imaging in medicine and surgery · 2023Article
- Deep learning based dental implant failure prediction from periapical and panoramic films.Quantitative imaging in medicine and surgery · 2023Article
- Research progress on deep learning in magnetic resonance imaging-based diagnosis and treatment of prostate cancer: a review on the current status and perspectives.Frontiers in oncology · 2023Review
- An interpretable deep learning approach for designing nanoporous silicon nitride membranes with tunable mechanical properties.npj computational materials · 2023Article
- How does the artificial intelligence-based image-assisted technique help physicians in diagnosis of pulmonary adenocarcinoma? A randomized controlled experiment of multicenter physicians in China.Journal of the American Medical Informatics Association : JAMIA · 2022Article
- Pix2Pix generative adversarial network for low dose myocardial perfusion SPECT denoising.Quantitative imaging in medicine and surgery · 2022Article
- [Chinese Experts Consensus on Artificial Intelligence Assisted Management for Pulmonary Nodule (2022 Version)].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2022Article
- Design and Implementation of Obstetric Central Monitoring System Based on Medical Image Segmentation Algorithm.Journal of healthcare engineering · 2022Article
- Models of Artificial Intelligence-Assisted Diagnosis of Lung Cancer Pathology Based on Deep Learning Algorithms.Journal of healthcare engineering · 2022Article
- Multi-channel multi-task deep learning for predictingQuantitative imaging in medicine and surgery · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe efficient and accurate diagnosis of pulmonary adenocarcinoma before surgery is of considerable significance to clinicians. Although computed tomography (CT) examinations are widely used in practice, it is still challenging and time-consuming for radiologists to distinguish between different types of subcentimeter pulmonary nodules. Although there have been many deep learning algorithms proposed, their performance largely depends on vast amounts of data, which is difficult to collect in the medical imaging area. Therefore, we propose an automatic classification system for subcentimeter pulmonary adenocarcinoma, combining a convolutional neural network (CNN) and a generative adversarial network (GAN) to optimize clinical decision-making and to provide small dataset algorithm design ideas.
methodsA total of 206 nodules with postoperative pathological labels were analyzed. Among them were 30 adenocarcinomas in situ (AISs), 119 minimally invasive adenocarcinomas (MIAs), and 57 invasive adenocarcinomas (IACs). Our system consisted of two parts, a GAN-based image synthesis, and a CNN classification. First, several popular existing GAN techniques were employed to augment the datasets, and comprehensive experiments were conducted to evaluate the quality of the GAN synthesis. Additionally, our classification system processes were based on two-dimensional (2D) nodule-centered CT patches without the need of manual labeling information.
resultsFor GAN-based image synthesis, the visual Turing test showed that even radiologists could not tell the GAN-synthesized from the raw images (accuracy: primary radiologist 56%, senior radiologist 65%). For CNN classification, our progressive growing wGAN improved the performance of CNN most effectively (area under the curve =0.83). The experiments indicated that the proposed GAN augmentation method improved the classification accuracy by 23.5% (from 37.0% to 60.5%) and 7.3% (from 53.2% to 60.5%) in comparison with training methods using raw and common augmented images respectively. The performance of this combined GAN and CNN method (accuracy: 60.5%±2.6%) was comparable to the state-of-the-art methods, and our CNN was also more lightweight.
conclusionsThe experiments revealed that GAN synthesis techniques could effectively alleviate the problem of insufficient data in medical imaging. The proposed GAN plus CNN framework can be generalized for use in building other computer-aided detection (CADx) algorithms and thus assist in diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.